Acrivon Therapeutics, Inc.
At Close: 4:00 PM
ACRV Stock Price Graph
ACRV Stock Price Today
Acrivon Therapeutics, Inc. (ACRV) stock rallied over 1.57% intraday to trade at $3.88 a share on NASDAQ. The stock opened with a gain of 41.36% at $5.40 and touched an intraday high of $5.40, rising 1.57% against the last close of $3.82. The Acrivon Therapeutics, Inc. in stock market went to a low of $4.96 during the session.
ACRV Stock Snapshot
Number of Shares
Cash Flow per Share
Free Float in %
ACRV Stock Price History Chart
Acrivon Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing oncology medicines for the patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's Acrivon Predictive Precision Proteomics, a precision medicine platform enables the creation of drug specific proprietary OncoSignature companion diagnostics that are used to identify the patients to benefit from its drug candidates. Its lead clinical candidate is ACR-368, a selective small molecule inhibitor targeting CHK1 and CHK2, which is in a potentially registrational Phase 2 trial across various tumor types, including platinum-resistant ovarian, endometrial, and bladder cancer. The company is also developing its preclinical stage pipeline programs targeting critical nodes in the DNA damage response and cell cycle regulation pathways, such as WEE1, a protein kinase and PKMYT1, a protein serine/threonine kinase. The company was incorporated in 2018 and is based in Watertown, Massachusetts.
Frequently Asked Questions
What is the current Acrivon Therapeutics, Inc. (ACRV) stock price?
Acrivon Therapeutics, Inc. (NASDAQ: ACRV) stock price is $3.88 in the last trading session. During the trading session, ACRV stock reached the peak price of $5.40 while $4.96 was the lowest point it dropped to. The percentage change in ACRV stock occurred in the recent session was 1.57% while the dollar amount for the price change in ACRV stock was $0.06.
ACRV's industry and sector of operation?
The NASDAQ listed ACRV is part of Biotechnology industry that operates in the broader Healthcare sector. Acrivon Therapeutics, Inc. , a clinical stage biopharmaceutical company, engages in developing oncology medicines for the patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform.
Who are the executives of ACRV?
Ms. Katharine Peterson CPA
Vice President of Fin. & Accounting
Ms. Kristina Masson M.B.A., Ph.D.
Co-Founder, Executive Vice President of Bus. Operations, Treasurer, Sec. & Director
Dr. Peter Blume-Jensen M.D., Ph.D.
Co-Founder, Chairman, Chief Executive Officer, Pres & Acting Chief Scientific Officer
Mr. Joon Jung Ph.D.
Vice President & Head of Data Science
How ACRV did perform over past 52-week?
ACRV's closing price is 0.40% higher than its 52-week low of $4.9605 where as its distance from 52-week high of $25.47 is -0.56%.
How many employees does ACRV have?
Number of ACRV employees currently stands at N/A. ACRV operates from 480 Arsenal Way<br/>Suite 100<br/>Watertown, MA 02472<br/>United States.
Link for ACRV official website?
Official Website of ACRV is: https://www.acrivon.com
How do I contact ACRV?
How many shares of ACRV are traded daily?
ACRV stock volume for the day was 21573.00 shares. The average number of ACRV shares traded daily for last 3 months was 19.41 Thousands.
What is the market cap of ACRV currently?
The market value of ACRV currently stands at $85.75 Million with its latest stock price at $3.88 and N/A of its shares outstanding.